Inventor · disambiguated record
Christopher M. Lindemann
Also filed as: LINDEMANN CHRISTOPHER · LINDEMANN CHRISTOPHER M
12 granted patents·14 pending applications·119 citations·filing 2004–2025
92Inventor score
Top patents by PatentIndex Score
26 records- 0194US10376590B2Sustained delivery formulations of risperidone compoundINDIVIOR UK LTD·Filed 2017·Granted Aug 13, 2019·10 cites·45 claims
- 0293US10143692B2Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2018·Granted Dec 4, 2018·7 cites·36 claims
- 0393US10010612B2Sustained delivery formulations of risperidone compoundsDADEY ERIC·Filed 2008·Granted Jul 3, 2018·21 cites·32 claims
- 0493US9889134B2Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2015·Granted Feb 13, 2018·8 cites·16 claims
- 0593US9168254B2Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2012·Granted Oct 27, 2015·15 cites·127 claims
- 0693US8313763B2Sustained delivery formulations of rapamycin compoundsMARGARON PHILIPPE MARIA CLOTAIRE·Filed 2007·Granted Nov 20, 2012·36 cites·19 claims
- 0790US10765678B2Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2018·Granted Sep 8, 2020·4 cites·19 claims
- 0889US11013809B2Sustained delivery formulations of risperidone compoundINDIVIOR UK LTD·Filed 2019·Granted May 25, 2021·4 cites·30 claims
- 0986US9457093B2Solid dispersions of a ERB2 (HER2) inhibitorARRAY BIOPHARMA INC·Filed 2012·Granted Oct 4, 2016·14 cites·24 claims
- 1083US2023135427A1Sustained delivery formulations of risperidone compoundINDIVIOR UK LTD·Filed 2022·Application pending·0 cites
- 1181US2023241066A1Polymorphs of arry-380, a selective her2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1279US2025326711A1Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereofPELOTON THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1378US11712475B2Sustained delivery formulations of risperidone compoundINDIVIOR UK LTD·Filed 2021·Granted Aug 1, 2023·0 cites·12 claims
- 1474US2023097309A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1572US11571424B2Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing themARRAY BIOPHARMA INC·Filed 2020·Granted Feb 7, 2023·0 cites·19 claims
- 1668US12358870B2Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereofPELOTON THERAPEUTICS INC·Filed 2019·Granted Jul 15, 2025·0 cites·12 claims
- 1766US2021220361A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1859US2019275043A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 1952US2017136022A1Solid dispersions of a erb2 (her2) inhibitorARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 2049US2018282324A1Crystalline forms of a pyrrolopyridine compoundGENENTECH INC·Filed 2017·Application pending·0 cites
- 2146US2015299182A1Crystalline forms of (1s)-1-[5-(amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diolARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 2244US2016251350A1Crystalline forms of a pyrrolopyridine compoundGENENTECH INC·Filed 2016·Application pending·0 cites
- 2342US2006287528A1Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitorWENSLOW ROBERT M·Filed 2004·Application pending·0 cites
- 2441US2006210604A1Ocular delivery of polymeric delivery formulationsDADEY ERIC·Filed 2005·Application pending·0 cites
- 2539US2008227786A1Novel Crystalline Salts of a Dipeptidyl Peptidase-IV InhibitorFERLITA RUSSELL R·Filed 2005·Application pending·0 cites
- 2639US2014094484A1Sustained delivery formulations of rapamycin compoundsCLOTAIRE MARGARON PHILIPPE MARIA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher M. Lindemann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →